Service d'urologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


678 publications

... | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ...
2017
 
Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
Valerio M., Dickinson L., Ali A., Ramachadran N., Donaldson I., Mccartan N., Freeman A., Ahmed H.U., Emberton M., 2017/03. The Journal of urology, 197 (3 Pt 1) pp. 647-654. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_93F05364D7E4]
 
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L., Cesson V., Lucca I., Cerantola Y., Valerio M., Fritschi U., Vlamopoulos Y., Burruni R., Legris A.S., Dartiguenave F. et al., 2017/02/01. Clinical cancer research, 23 (3) pp. 717-725. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E871163C3ED]
 
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study.
Mathieu R., Lucca I., Vartolomei M.D., Mbeutcha A., Klatte T., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y. et al., 2017/02. BJU international, 119 (2) pp. 234-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_35622816445B]
 
The Swiss Kidney Stone Cohort: An Observational Study to Unravel the Cause of Renal Stone Formation.
Roth B., Bonny O., Swiss Kidney Stone Cohort Investigators, 2017/02. European urology focus, 3 (1) pp. 7-9. Peer-reviewed.
[DOI][Pmid][serval:BIB_86A925F507FC]
 
Urologie [Urology : therapeutics news in 2016]
Jichlinski P., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 110-111. Peer-reviewed.
[Pmid][serval:BIB_4BA913E11B13]
Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
Spodzieja M., Lach S., Iwaszkiewicz J., Cesson V., Kalejta K., Olive D., Michielin O., Speiser D.E., Zoete V., Derré L. et al., 2017. PloS one, 12 (6) pp. e0179201.
[URN][DOI][WoS][Pmid][serval:BIB_8C02B51C71F2]
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
Chevalier M.F., Trabanelli S., Racle J., Salomé B., Cesson V., Gharbi D., Bohner P., Domingos-Pereira S., Dartiguenave F., Fritschi A.S. et al., 2017. The Journal of Clinical Investigation, 127 (8) pp. 2916-2929. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA350D3E0400]
 
Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intent.
Gauvin S., Cerantola Y., Haberer E., Pelsser V., Probst S., Bladou F., Anidjar M., 2017. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 11 (1-2) pp. 47-52. Peer-reviewed.
[DOI][Pmid][serval:BIB_CC6622B325A6]
 
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M., Cerantola Y., Eggener S.E., Lepor H., Polascik T.J., Villers A., Emberton M., 2017/01. European urology, 71 (1) pp. 17-34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C48D18F9D56D]
 
Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Jacqmin D., Jichlinski P., Molinier L., de la Taille A., Irani J., Malavaud B., 2017. Urologia internationalis, 99 (3) pp. 358-366. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC8D65FA3FB1]
 
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
Domingos-Pereira S., Cesson V., Chevalier M.F., Derré L., Jichlinski P., Nardelli-Haefliger D., 2017. Oncoimmunology, 6 (1) pp. e1265720. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1971614566E5]
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei M.D., Mathieu R., Margulis V., Karam J.A., Rouprêt M., Lucca I., Mbeutcha A., Seitz C., Karakiewicz P.I., Fajkovic H. et al., 2017/01. World journal of urology, 35 (1) pp. 121-130. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_24DDB6EC6BD8]
2016
 
Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
Vidal A., Arnold N., Vartolomei M.D., Kiss B., Burkhard F., Thalmann G.N., Roth B., 2016/12. International journal of urology, 23 (12) pp. 992-999. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0F4EDAAB8BF]
 
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey.
Bultijnck R., Surcel C., Ploussard G., Briganti A., De Visschere P., Fütterer J., Ghadjar P., Giannarini G., Isbarn H., Massard C. et al., 2016/12. European urology focus, 2 (5) pp. 514-521. Peer-reviewed.
[DOI][Pmid][serval:BIB_6764FCF6F372]
 
Bilan et traitements des infections urogénitales [Assessment and treatment of genitourinary infections]
Martel P., M'Baya O., Senn L., Jichlinski P., Cerantola Y., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2054-2059. Peer-reviewed.
[Pmid][serval:BIB_E9900C6E885A]
 
Médicaments usuels en médecine de premier recours et cancer de la prostate : quelle relation ? [Common medications and prostate cancer : what is the association ?]
Rakauskas A., Grilo N., M'Baya O., Jichlinski P., Valerio M., Berthold D., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2068-2071. Peer-reviewed.
[Pmid][serval:BIB_A37D39541A4B]
 
Prise en charge des traumatismes urogénitaux [Management of genitourinary trauma]
Perrin A., Grilo N., Meuwly J.Y., Jichlinski P., Valerio M., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2072-2076. Peer-reviewed.
[Pmid][serval:BIB_578D4A48280E]
 
Vers une réforme « concertée » de l’incitatif financier dans le système de santé ?
Jichlinski P., Iselin C.E., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2051-2052. Peer-reviewed.
[Pmid][serval:BIB_038A3A50384E]
 
Le traitement standard du cancer de la vessie non musculo-invasif avec du BCG peut être associé à une vaccination anti-cancer pour augmenter la réponse vaccinale cellulaire T locale
Jichlinski P., Derré L., Nardell-Haefliger D., Speiser D., Romero P., 2016/11., Société française d'urologie p. 705 dans 110e Congrès français d'urologie, Progrès en Urologie.
[DOI][serval:BIB_22CC3EAF8590]
 
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Mbeutcha A., Shariat S.F., Rieken M., Rink M., Xylinas E., Seitz C., Lucca I., Mathieu R., Rouprêt M., Briganti A. et al., 2016/11. Urologic oncology, 34 (11) pp. 483.e17-483.e24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5833EAC86D3D]
 
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
Baumgaertner P., Costa Nunes C., Cachot A., Maby-El Hajjami H., Cagnon L., Braun M., Derré L., Rivals J.-P., Rimoldi D., Gnjatic S. et al., 2016/10/02. OncoImmunology, 5 (10) pp. e1216290.
[DOI][WoS][Pmid][serval:BIB_B9A2EC467477]
 
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Fajkovic H., Shariat S.F., Klatte T., Vartolomei M.D., Lucca I., Mbeutcha A., Rouprêt M., Briganti A., Karakiewicz P.I., Margulis V. et al., 2016/10. World journal of urology, 34 (10) pp. 1411-1419. Peer-reviewed.
[DOI][Pmid][serval:BIB_999DE1F51220]
 
Patients with an Orthotopic Low Pressure Bladder Substitute Enjoy Long-Term Good Function.
Furrer M.A., Roth B., Kiss B., Nguyen D.P., Boxler S., Burkhard F.C., Thalmann G.N., Studer U.E., 2016/10. The Journal of urology, 196 (4) pp. 1172-1180. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F226ECE1E745]
 
Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I., Hofbauer S.L., Leitner C.V., de Martino M., Özsoy M., Susani M., Shariat S.F., Klatte T., 2016/09. Urology, 95 pp. 132-138. Peer-reviewed.
[DOI][Pmid][serval:BIB_4F30218C63DB]
 
IGF-1-containing multi-layered collagen-fibrin hybrid scaffolds for bladder tissue engineering.
Vardar E., Larsson H.M., Engelhardt E.M., Pinnagoda K., Briquez P.S., Hubbell J.A., Frey P., 2016/09/01. Acta biomaterialia, 41 pp. 75-85. Peer-reviewed.
[DOI][Pmid][serval:BIB_13F36BD33BFE]
The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial.
El-Shater Bosaily A., Valerio M., Hu Y., Freeman A., Jameson C., Brown L., Kaplan R., Hindley R.G., Barratt D., Emberton M. et al., 2016/09. Prostate cancer and prostatic diseases, 19 (3) pp. 258-263. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_68039086F327]
 
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
Mbeutcha A., Lucca I., Margulis V., Karam J.A., Wood C.G., de Martino M., Mathieu R., Haitel A., Xylinas E., Kluth L. et al., 2016/08. World journal of urology, 34 (8) pp. 1155-1161. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3ADE8ED294E]
 
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.
Mathieu R., Lucca I., Rouprêt M., Briganti A., Shariat S.F., 2016/08. Nature reviews. Urology, 13 (8) pp. 471-479. Peer-reviewed.
[DOI][Pmid][serval:BIB_3BBD34AEAF12]
 
Cambiando la vía de manejo del cáncer de próstata: ¿Por qué la Terapia Focal es un paso adelante? [Changing the prostate cancer management pathway: why Focal Therapy is a step forward]
Marra G., Gontero P., Valerio M., 2016/07. Archivos espanoles de urologia, 69 (6) pp. 271-280. Peer-reviewed.
[Pmid][serval:BIB_C0C94E3CD803]
 
Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Lucca I., Shariat S.F., 2016/07. European urology, 70 (1) pp. 205-206. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B866896273E0]
 
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H., Mathieu R., Lucca I., Hiess M., Hübner N., Al Hussein Al Awamlh B., Lee R., Briganti A., Karakiewicz P., Lotan Y. et al., 2016/05. Urologic oncology, 34 (5) pp. 233.e1-6. Peer-reviewed.
[DOI][Pmid][serval:BIB_B6DDD7225AF7]
 
Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.
Vartolomei M.D., Kiss B., Vidal A., Burkhard F., Thalmann G.N., Roth B., 2016/04. BJU international, 117 (4) pp. 618-628. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15252F140738]
 
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis.
Lucca I., Jichlinski P., Shariat S.F., Rouprêt M., Rieken M., Kluth L.A., Rink M., Mathieu R., Mbeutcha A., Maj-Hes A. et al., 2016/04. European urology focus, 2 (1) pp. 79-85. Peer-reviewed.
[DOI][Pmid][serval:BIB_5B2803795184]
 
The role of minimally invasive surgery on enhanced recovery after nephrectomy
M'Baya Olivier, Grilo Nuno, Valerio Massimo, Dartiguenave Florence, Puricel Serban, Blanc Catherine, Jichlinski Patrice, Cerantola Yannick, 2016/04. pp. e52 dans Clinical Nutrition ESPEN.
[DOI][serval:BIB_2256BCEFBB19]
Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion.
Alonso F., Domingos-Pereira S., Le Gal L., Derré L., Meda P., Jichlinski P., Nardelli-Haefliger D., Haefliger J.A., 2016/03/22. Oncotarget, 7 (12) pp. 14015-14028. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_42D2A2696272]
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James N.D., Sydes M.R., Clarke N.W., Mason M.D., Dearnaley D.P., Spears M.R., Ritchie A.W., Parker C.C., Russell J.M., Attard G. et al., 2016/03/19. Lancet (London, England), 387 (10024) pp. 1163-1177. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2BB6C537D055]
Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
Hojeij R., Domingos-Pereira S., Nkosi M., Gharbi D., Derré L., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2016/03/14. International journal of molecular sciences, 17 (7) pp. E1125. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_43FA35E9A155]
 
Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial.
Skuginna V., Nguyen D.P., Seiler R., Kiss B., Thalmann G.N., Roth B., 2016/02. European urology, 69 (2) pp. 267-273. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D82CD48CF6FB]
Reply from Authors to the Editorial Comment.
Kiss B., Roth B., 2016/01/28. Bladder cancer, 2 (1) pp. 63-64. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3C7579E87F7B]
Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological Radicality.
Kiss B., Paerli M., Schöndorf D., Burkhard F.C., Thalmann G.N., Roth B., 2016/01/07. Bladder cancer, 2 (1) pp. 53-59. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DECA9F138ECD]
 
Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
Cerantola Y., Haberer E., Torres J., Alameldin M., Aronson S., Levental M., Bladou F., Anidjar M., 2016/01. World journal of urology, 34 (1) pp. 75-82. Peer-reviewed.
[DOI][Pmid][serval:BIB_804F7A5F4F41]
 
Addressing overtreatment following the diagnosis of localized prostate cancer.
Tawadros T., Valerio M., 2016. Expert Review of Anticancer Therapy, 16 (4) pp. 373-374. Peer-reviewed.
[DOI][Pmid][serval:BIB_F63BFDE5E128]
 
Analyse de l’infiltration immunitaire au cours des instillations intravésicales de BCG : identification d’un profil immunosuppressif prédictif de la récidive tumorale
Chevalier M., Trabanelli S., Gharbi D., Cesson V., Domingos-Pereira S., Dartiguenave F., Fritschi A., Speiser D., Romero P., Jandus C. et al., 2016., Société française d'urologie p. 707 dans 110e Congrès français d'urologie, Progres en urologie .
[DOI][serval:BIB_D847F7806040]
 
Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer.
Cerantola Y., Dragomir A., Tanguay S., Bladou F., Aprikian A., Kassouf W., 2016. Urologic Oncology, 34 (3) pp. 119.e1-119.e9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14378742BD59]
 
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
Mbeutcha A., Lucca I., Mathieu R., Lotan Y., Shariat S.F., 2016. Urologic Clinics of North America, 43 (1) pp. 47-62. Peer-reviewed.
[DOI][Pmid][serval:BIB_A2BABDD19CB1]
 
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study.
Mathieu R., Klatte T., Lucca I., Mbeutcha A., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y., Scherr D.S. et al., 2016. Bju International, 118 (2) pp. 243-249. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E34A8C3EC884]
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.
De Visschere P.J., Briganti A., Fütterer J.J., Ghadjar P., Isbarn H., Massard C., Ost P., Sooriakumaran P., Surcel C.I., Valerio M. et al., 2016. Insights Into Imaging, 7 (2) pp. 205-214. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_323E63FC3C89]
 
Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy.
Weiss L., Chevalier M.F., Assoumou L., Paul J.L., Alhenc-Gelas M., Didier C., Taibi S., Manea E.M., Campa P., Girard P.M. et al., 2016. Journal of Acquired Immune Deficiency Syndromes (1999), 71 (4) pp. 390-398. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E22BF0297D71]
 
The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping Biopsies.
Valerio M., Anele C., Bott S.R., Charman S.C., van der Meulen J., El-Mahallawi H., Emara A.M., Freeman A., Jameson C., Hindley R.G. et al., 2016. Journal of Urology, 195 (5) pp. 1403-1408. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_49D93E3090FF]
 
The role of renal biopsy in small renal masses.
Burruni R., Lhermitte B., Cerantola Y., Tawadros T., Meuwly J.Y., Berthold D., Jichlinski P., Valerio M., 2016. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10 (1-2) pp. E28-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E17D73E719CC]
 
Transperineal template prostate-mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer.
Valerio M., Anele C., Charman S.C., van der Meulen J., Freeman A., Jameson C., Singh P.B., Emberton M., Ahmed H.U., 2016. Bju International, 118 (3) pp. 384-390. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4973EEDBFA00]
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8(+) and CD4(+) T-cell responses with multiple specificities including a novel DR7-restricted epitope.
Baumgaertner P., Costa Nunes C., Cachot A., Maby-El Hajjami H., Cagnon L., Braun M., Derré L., Rivals J.P., Rimoldi D., Gnjatic S. et al., 2016. Oncoimmunology, 5 (10) pp. e1216290. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A6A68301DF3E]
2015
 
Incontinence urinaire chez la femme âgée: que faire au cabinet? [Urinary incontinence in older women: what can a GP do?]
Ernst V., Saïah L., Cerantola Y., Bosshard Taroni W., Haftgoli N., Büla C., 2015/11/11. Revue medicale suisse, 11 (494) pp. 2104,2106-2109. Peer-reviewed.
[Pmid][serval:BIB_C3E8E7A7403D]
 
Optimization of Extracorporeal Shock Wave Lithotripsy Delivery Rates Achieves Excellent Outcomes for Ureteral Stones: Results of a Prospective Randomized Trial.
Nguyen D.P., Hnilicka S., Kiss B., Seiler R., Thalmann G.N., Roth B., 2015/08. The Journal of urology, 194 (2) pp. 418-423. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E933B9C674C5]
Standard cystectomy fits all: truth or myth?
Roth B., Thalmann G.N., 2015/06. Translational andrology and urology, 4 (3) pp. 254-260. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F437A91DBBF]
 
Cancer testiculaire: un modèle pour optimiser le suivi radiologique [Testicular cancer: a model to optimize the radiological follow-up].
Stebler V., Pauchard B., Schmidt S., Valerio M., De Bari B., Berthold D., 2015/05. Revue Médicale Suisse, 11 (475) pp. 1144-1148.
[Pmid][serval:BIB_1E2A61B344CE]
 
Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?
Kiss B., Schneider S., Thalmann G.N., Roth B., 2015/02. International journal of urology, 22 (2) pp. 158-162. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21CE2449D8C5]
 
A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer.
Willis S.R., van der Meulen J., Valerio M., Miners A., Ahmed H.U., Emberton M., 2015. Current Opinion In Urology, 25 (6) pp. 483-489. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F9DE99507C2]
 
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I., Rouprêt M., Kluth L., Rink M., Tilki D., Fajkovic H., Kassouf W., Hofbauer S.L., de Martino M., Karakiewicz P.I. et al., 2015. Bju International, 115 (5) pp. 722-727. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD1E0840E9EA]
 
Biopsies de la prostate en 2015: quelle biopsie pour quel patient [Prostate biopsy: which strategy for which patient?].
Burruni R., Cerantola Y., Meuwly J.Y., Tawadros T., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (497) pp. 2288-90, 2292.
[Pmid][serval:BIB_84B39813FF24]
 
Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.
Lucca I., de Martino M., Hofbauer S.L., Zamani N., Shariat S.F., Klatte T., 2015. World Journal of Urology, 33 (12) pp. 2045-2052. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_62D2B7FA1B22]
 
Compliance with preoperative oral nutritional supplements in patients at nutritional risk─only a question of will?
Grass F., Bertrand P.C., Schäfer M., Ballabeni P., Cerantola Y., Demartines N., Hübner M., 2015. European Journal of Clinical Nutrition, 69 (4) pp. 525-529. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E2E6BA056C9]
 
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
Valerio M., Donaldson I., Emberton M., Ehdaie B., Hadaschik B.A., Marks L.S., Mozer P., Rastinehad A.R., Ahmed H.U., 2015. European Urology, 68 (1) pp. 8-19. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_686C3618BA3C]
 
Diagnosis and Management of Upper Tract Urothelial Carcinoma.
Lucca I., Leow J.J., Shariat S.F., Chang S.L., 2015. Hematology/oncology Clinics of North America, 29 (2) pp. 271-288. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A6E7CF897D87]
 
Dysfunction of lower urinary tract in patients with spinal cord injury.
Schurch B., Tawadros C., Carda S., 2015. Handbook of Clinical Neurology, 130 pp. 247-267. Peer-reviewed.
[DOI][Pmid][serval:BIB_E03A522D02C2]
 
Dépistage du cancer de la prostate: partager avec le patient les incertitudes [Sharing uncertainties of prostate cancer screening].
Selby K., Auer R., Valerio M., Jichlinski P., Cornuz J., 2015. Revue Médicale Suisse, 11 (496) pp. 2216, 2218-2216, 2220.
[Pmid][serval:BIB_2E2F578888E0]
 
External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.
Tawadros C., Burnett K., Derbyshire L.F., Tawadros T., Clarke N.W., Betts C.D., 2015. Bju International, 116 (3) pp. 423-431. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_447BC24476CC]
 
Focal Therapy of Prostate Cancer Using Irreversible Electroporation.
Valerio M., Ahmed H.U., Emberton M., 2015. Techniques in Vascular and Interventional Radiology, 18 (3) pp. 147-152. Peer-reviewed.
[DOI][Pmid][serval:BIB_4829CA2C0D35]
 
High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools.
Chevalier M.F., Bobisse S., Costa-Nunes C., Cesson V., Jichlinski P., Speiser D.E., Harari A., Coukos G., Romero P., Nardelli-Haefliger D. et al., 2015. Oncoimmunology, 4 (10) pp. e1029702. Peer-reviewed.
[DOI][Pmid][serval:BIB_FC441F50334F]
 
Histopathology and prognosis of de novo bladder tumors following solid organ transplantation.
Ederer I.A., Lucca I., Hofbauer S.L., Haidinger M., Haitel A., Susani M., Shariat S.F., Klatte T., 2015. World Journal of Urology, 33 (12) pp. 2087-2093. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2C00A97F7D92]
 
Identifying the index lesion with template prostate mapping biopsies.
Valerio M., Anele C., Freeman A., Jameson C., Singh P.B., Hu Y., Emberton M., Ahmed H.U., 2015. Journal of Urology, 193 (4) pp. 1185-1190. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C17BA00B68EE]
 
Inégalité des sexes face au cancer en urologie [Gender disparities in urologic cancers].
Lucca I., Valerio M., Jichlinski P., Cerantola Y., 2015. Revue Médicale Suisse, 11 (497) pp. 2276-8, 2280.
[Pmid][serval:BIB_F61CE55212D3]
 
Kidney-sparing surgery for upper tract urothelial cancer.
Lucca I., Klatte T., Rouprêt M., Shariat S.F., 2015. Current Opinion in Urology, 25 (2) pp. 100-104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD37600480F3]
 
Le rapport neutrophiles/lymphocytes est un facteur prédictif indépendant de récidive et de progression dans les tumeurs de vessie non infiltrantes.
Mbeutcha A., Lucca I., De Martino M., Mathieu R., Rieken M., Xylinas E., Kluth L., Crivelli J., Lotan Y., Shariat S. et al., 2015. Progrès En Urologie : Journal De L'association Française D'urologie et De La Société Française D'urologie, 25 (13) pp. 759-760. Peer-reviewed.
[DOI][Pmid][serval:BIB_46EB7D9F2474]
Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.
Domingos-Pereira S., Hojeij R., Reggi E., Derré L., Chevalier M.F., Romero P., Jichlinski P., Nardelli-Haefliger D., 2015. Oncoimmunology, 4 (7) pp. e1016697. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4AEADA8DF103]
 
Methodological considerations in assessing the utility of imaging in early prostate cancer.
Valerio M., Willis S., van der Meulen J., Emberton M., Ahmed H.U., 2015. Current Opinion in Urology, 25 (6) pp. 536-542. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3A60C71A900]
 
MRI/TRUS fusion software-based targeted biopsy: the new standard of care?
Manfredi M., Costa Moretti T.B., Emberton M., Villers A., Valerio M., 2015. Minerva Urologica e Nefrologica, 67 (3) pp. 233-246. Peer-reviewed.
[WoS][Pmid][serval:BIB_039DA3FB7A5A]
 
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.
Mathieu R., Shariat S.F., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y., Scherr D.S., Tewari A., Montorsi F. et al., 2015. World Journal of Urology, 33 (8) pp. 1165-1171. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_66B956D8A844]
 
Novel biomarkers to predict response and prognosis in localized bladder cancer.
Lucca I., de Martino M., Klatte T., Shariat S.F., 2015. Urologic Clinics of North America, 42 (2) pp. 225-33, ix. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B4A681FC901]
 
Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis.
Lucca I., Shariat S.F., Hofbauer S.L., Klatte T., 2015. World Journal of Urology, 33 (4) pp. 563-570. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A44D4E74F633]
Preoperative nutritional screening by the specialist instead of the nutritional risk score might prevent excess nutrition: a multivariate analysis of nutritional risk factors.
Grass F., Hübner M., Schäfer M., Ballabeni P., Cerantola Y., Demartines N., Pralong F.P., Bertrand P.C., 2015. Nutrition Journal, 14 (1) p. 37. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07783E6403AF]
 
The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma.
Hofbauer S.L., Pantuck A.J., de Martino M., Lucca I., Haitel A., Shariat S.F., Belldegrun A.S., Klatte T., 2015. Urologic Oncology, 33 (2) pp. 68.e1-68.e7. Peer-reviewed.
[DOI][Pmid][serval:BIB_3C92C45C7428]
 
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
Lucca I., Kassouf W., Kapoor A., Fairey A., Rendon R.A., Izawa J.I., Black P.C., Fajkovic H., Seitz C., Remzi M. et al., 2015. BJU International, 116 (1) pp. 72-78. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2359E9AA3C78]
 
The T309G Murine Double Minute 2 Gene Polymorphism Is an Independent Prognostic Factor for Patients with Renal Cell Carcinoma.
de Martino M., Taus C., Wessely I.S., Lucca I., Hofbauer S.L., Haitel A., Shariat S.F., Klatte T., 2015. Dna and Cell Biology, 34 (2) pp. 107-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E55F7CC9B9AA]
 
Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
Mathieu R., Lucca I., Klatte T., Babjuk M., Shariat S.F., 2015. Current Opinion In Urology, 25 (5) pp. 476-482. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DCA46EB3142C]
Upper urinary tract disease: what we know today and unmet needs
Mathieu , Bensalah , Lucca , Mbeutcha , Rouprêt , Shariat , 2015. Translational Andrology and Urology, 4 (3) pp. 261-272. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C09105C57C8D]
 
Urologie [Urology].
Boldini M., Cerantola Y., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (456-457) pp. 143-147.
[Pmid][serval:BIB_6B7F6BB57F82]
 
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
Lucca I., Shariat S.F., Briganti A., Lotan Y., Roehrborn C.G., Montorsi F., Remzi M., Seitz C., Fajkovic H., Klingler C. et al., 2015. Urologic Oncology, 33 (2) pp. 71.e21-71.e26. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DCD023CAB4C6]
 
Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer.
Valerio M., McCartan N., Freeman A., Punwani S., Emberton M., Ahmed H.U., 2015. Urologic Oncology, 33 (10) pp. 424.e9-424.16.
[DOI][WoS][Pmid][serval:BIB_271EB9B3B077]
2014
 
Functional multiparametric magnetic resonance imaging of the kidneys using blood oxygen level dependent and diffusion-weighted sequences.
Giannarini G., Kessler T.M., Roth B., Vermathen P., Thoeny H.C., 2014/08. The Journal of urology, 192 (2) pp. 434-439. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A6B71517B54]
 
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Zehnder P., Studer U.E., Daneshmand S., Birkhäuser F.D., Skinner E.C., Roth B., Miranda G., Burkhard F.C., Cai J., Skinner D.G. et al., 2014/04. BJU international, 113 (4) pp. 554-560. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_000B9DA4C5C8]
 
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Choi W., Porten S., Kim S., Willis D., Plimack E.R., Hoffman-Censits J., Roth B., Cheng T., Tran M., Lee I.L. et al., 2014/02/10. Cancer cell, 25 (2) pp. 152-165. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C137742E6EEF]
A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
Valerio M., Dickinson L., Ali A., Ramachandran N., Donaldson I., Freeman A., Ahmed H.U., Emberton M., 2014. Contemporary Clinical Trials, 39 (1) pp. 57-65.
[URN][DOI][WoS][Pmid][serval:BIB_EB1614BDCFCB]
Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig cells and adult human testis.
Vaucher L., Funaro M.G., Mehta A., Mielnik A., Bolyakov A., Prossnitz E.R., Schlegel P.N., Paduch D.A., 2014. Plos One, 9 (4) pp. e92425.
[URN][DOI][WoS][Pmid][serval:BIB_3DBD13D58169]
Associations Between Presenting Symptoms, Clinicopathological Parameters, and Prognosis in a Contemporary Series of Patients With Renal Cell Carcinoma
Hofbauer S.L., de Martino M., Seemann C., Zamani N., Lucca I., Haitel A., Shariat S.F., Klatte T., 2014. Korean Journal of Urology, 55 (8) pp. 505-510. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4E7C776F2378]
 
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P., 2014. Canadian Urological Association Journal, 8 (9-10) pp. E600-E604. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FAAFB52000CA]
 
Defining the level of evidence for technology adoption in the localized prostate cancer pathway.
Valerio M., El-Shater Bosaily A., Emberton M., Ahmed H.U., 2014. Urologic Oncology, 32 (6) pp. 924-930. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD52F90960C9]
 
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?
Patel H.R., Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Müller S., Baldini G. et al., 2014. European Urology, 65 (2) pp. 263-266. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A6A1760D9CF4]
Focal therapy will become a standard option for selected men with localized prostate cancer.
Valerio M., Emberton M., Ahmed H.U., 2014. Journal of Clinical Oncology, 32 (32) pp. 3680-3681. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CD7F9A7EC388]
 
Fungus ball in the urinary tract: A rare entity.
Praz V., Burruni R., Meid F., Wisard M., Jichlinski P., Tawadros T., 2014. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 8 (1-2) pp. E118-E120.
[DOI][Pmid][serval:BIB_FE30C5EF00B9]
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.
Vasilevsky S., Greub G., Nardelli-Haefliger D., Baud D., 2014. Clinical Microbiology Reviews, 27 (2) pp. 346-370.
[URN][DOI][WoS][Pmid][serval:BIB_D2BD1C58B933]
 
Health technology assessment in evolution - focal therapy in localised prostate cancer.
Valerio M., Emberton M., Barret E., Eberli D., Eggener S.E., Ehdaie B., Jichlinski P., Ward J.F., Ahmed H.U., 2014. Expert Review of Anticancer Therapy, 14 (11) pp. 1359-1367. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C52345D9509B]
Immunotherapeutic strategies for bladder cancer.
Chevalier M.F., Nardelli-Haefliger D., Domingos-Pereira S., Jichlinski P., Derré L., 2014. Human Vaccines and Immunotherapeutics, 10 (4) pp. 977-981. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_A25269F0E43E]
 
In vivo measurement of tissue oxygenation by time-resolved luminescence spectroscopy: advantageous properties of dichlorotris(1, 10-phenanthroline)-ruthenium(II) hydrate.
Huntosova V., Gay S., Nowak-Sliwinska P., Rajendran S.K., Zellweger M., van den Bergh H., Wagnières G., 2014. Journal of Biomedical Optics, 19 (7) p. 77004. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_164551A3CC11]
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.
Valerio M., Stricker P.D., Ahmed H.U., Dickinson L., Ponsky L., Shnier R., Allen C., Emberton M., 2014. Prostate Cancer and Prostatic Diseases, 17 (4) pp. 343-347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22E52AF9AAD1]
 
Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.
Domingos-Pereira S., Derré L., Warpelin-Decrausaz L., Haefliger J.A., Romero P., Jichlinski P., Nardelli-Haefliger D., 2014. Journal of Urology, 191 (3) pp. 814-822.
[URN][DOI][WoS][Pmid][serval:BIB_5CCCD4E4842E]
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.
Weiss A., van Beijnum J.R., Bonvin D., Jichlinski P., Dyson P.J., Griffioen A.W., Nowak-Sliwinska P., 2014. Journal of Cellular and Molecular Medicine, 18 (3) pp. 480-491. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_823C6E755633]
 
Optical spectroscopy of the bladder washout fluid to optimize fluorescence cystoscopy with Hexvix®.
Martoccia C., Zellweger M., Lovisa B., Jichlinski P., van den Bergh H., Wagnières G., 2014. Journal of Biomedical Optics, 19 (9) p. 97002. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47DF56D93571]
Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.
Kilarski W.W., Muchowicz A., Wachowska M., Mężyk-Kopeć R., Golab J., Swartz M.A., Nowak-Sliwinska P., 2014. Angiogenesis, 17 (2) pp. 347-357. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB356E01B697]
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
Hofbauer S.L., Stangl K.I., de Martino M., Lucca I., Haitel A., Shariat S.F., Klatte T., 2014. British Journal of Cancer, 111 (8) pp. 1526-1531. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F715C43D92F]
 
Re: jarow et Al.: drug and device development for localized prostate cancer: report of a food and drug administration/american urological association public workshop (urology 2014;83:975-979).
Valerio M., Emberton M., Ahmed H.U., 2014. Urology, 84 (3) pp. 732-733.
[DOI][WoS][Pmid][serval:BIB_A25E60BAF207]
 
Re: tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?: f. Cornud, g. Khoury, N. Bouazza, f. Beuvon, m. Peyromaure, T. Flam, m. Zerbib, p. Legmann and N. B. Delongchamps j urol 2014; 191: 1272-1279.
Valerio M., Ahmed H.U., 2014. Journal of Urology, 192 (4) pp. 1297-1298.
[DOI][WoS][Pmid][serval:BIB_331E7FA54420]
 
Restoration of connexin 40 (cx40) in Renin-producing cells reduces the hypertension of cx40 null mice.
Le Gal L., Alonso F., Wagner C., Germain S., Nardelli Haefliger D., Meda P., Haefliger J.A., 2014. Hypertension, 63 (6) pp. 1198-1204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A5937C56810]
 
Sex steroids and gender differences in nonmuscle invasive bladder cancer.
Lucca I., Fajkovic H., Klatte T., 2014. Current Opinion In Urology, 24 (5) pp. 500-505. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C4E930B9AA7]
 
T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection.
Weiss L., Chevalier M.F., Assoumou L., Didier C., Girard P.M., Piketty C., Costagliola D., Rouzioux C., ANRS 116 SALTO Study Group, 2014. Aids (london, England), 28 (11) pp. 1683-1687. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_59F3943B3CA5]
The role of focal therapy in the management of localised prostate cancer: a systematic review.
Valerio M., Ahmed H.U., Emberton M., Lawrentschuk N., Lazzeri M., Montironi R., Nguyen P.L., Trachtenberg J., Polascik T.J., 2014. European Urology, 66 (4) pp. 732-751. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C0A1B52AB56C]
 
Thérapie focale du cancer de la prostate: rationnel, résultats et perspectives [Focal therapy in prostate cancer: rationale, results and perspectives].
Valerio M., Benamran D., Tawadros T., Cerantola Y., Meuwly J.Y., Lutchmaya-Flick C., Lhermitte B., Wirth G., Iselin C., Jichlinski P., 2014. Revue Médicale Suisse, 10 (453) pp. 2306-2310. Peer-reviewed.
[Pmid][serval:BIB_E22C4882AE84]
 
Urologie [Urology].
Jichlinski P., 2014. Revue Médicale Suisse, 10 (412-413) pp. 127-129.
[Pmid][serval:BIB_4B1000E593B8]
 
Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer.
Lucca I., Klatte T., Shariat S.F., 2014. European Urology, 66 (2) pp. 386-387. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_524E2A8079FD]
2013
 
Novel prototype sewing device, EndoSew®, for minimally invasive surgery: an extracorporeal ileal conduit construction pilot study in 10 patients.
Roth B., Birkhäuser F.D., Thalmann G.N., Zehnder P., 2013/11. BJU international, 112 (7) pp. 959-964. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A38AC78FBD3B]
 
Stricture of the afferent isoperistaltic tubular segment: a late and rare cause of bilateral dilation of the upper urinary tract after ileal bladder substitution.
Kiss B., Schöndorf D., Studer U.E., Roth B., 2013/08. Urology, 82 (2) pp. 466-470. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB322CDE3AF5]
 
Ureteroileal strictures after urinary diversion with an ileal segment-is there a place for endourological treatment at all?
Schöndorf D., Meierhans-Ruf S., Kiss B., Giannarini G., Thalmann G.N., Studer U.E., Roth B., 2013/08. The Journal of urology, 190 (2) pp. 585-590. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1F349EA81449]
 
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.
Zehnder P., Studer U.E., Skinner E.C., Thalmann G.N., Miranda G., Roth B., Cai J., Birkhäuser F.D., Mitra A.P., Burkhard F.C. et al., 2013/07. BJU international, 112 (2) pp. E51-8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1A08A57CA46F]
 
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial.
Roth B., Birkhäuser F.D., Zehnder P., Thalmann G.N., Huwyler M., Burkhard F.C., Studer U.E., 2013/03. European urology, 63 (3) pp. 475-482. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45CB73D58806]
 
Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms.
Moltzahn F., Haeni K., Birkhäuser F.D., Roth B., Thalmann G.N., Zehnder P., 2013/02. BJU international, 111 (2) pp. 289-295. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8CEE20CF1759]
 
Are patients at nutritional risk more prone to complications after major urological surgery?
Cerantola Y., Valerio M., Hubner M., Iglesias K., Vaucher L., Jichlinski P., 2013. Journal of Urology, 190 (6) pp. 2126-2132. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE1935BCC10C]
 
Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?
Cerantola Y., Valerio M., Kawkabani Marchini A., Meuwly J.Y., Jichlinski P., 2013. Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada, 7 (11-12) pp. E699-E703. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D6CAE6A7B117]
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
Corgnac S., Perret R., Derré L., Zhang L., Stirnemann K., Zauderer M., Speiser D.E., Mach J.P., Romero P., Donda A., 2013. Cancer Immunology, Immunotherapy, 62 (4) pp. 747-760.
[URN][DOI][WoS][Pmid][serval:BIB_ED058D025B50]
 
Centre de la prostate: une approche multidisciplinaire pour une prise en charge globale du patient [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer]
Tawadros T., Burruni R., Herrera F., Codeluppi C., Zurkinden C., Meuwly J.Y., Lhermitte B., Berthold D., 2013. Revue Médicale Suisse, 9 (409) pp. 2270-2, 2274.
[Pmid][serval:BIB_AA917B8978EC]
 
CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.
Thibult M.L., Rivals J.P., Mamessier E., Gertner-Dardenne J., Pastor S., Speiser D.E., Derré L., Olive D., 2013. Journal of Molecular Medicine, 91 (2) pp. 195-205.
[URN][DOI][WoS][Pmid][serval:BIB_41EC0257E313]
 
Deep vein thrombosis of the penis: an unusual but severe complication of prostatic abscess.
Calanca L., Alatri A., Schaller M.D., Sermier A., Mazzolai L., 2013. Vasa. Zeitschrift Für Gefässkrankheiten, 42 (3) pp. 214-217.
[DOI][WoS][Pmid][serval:BIB_4DEDE37A5B18]
 
Experimental evaluation of an electromechanical artificial urinary sphincter in an animal model.
Valerio M., Jichlinski P., Dahlem R., Tozzi P., Mundy A.R., 2013. BJU International, 112 (4) pp. E337-E343.
[DOI][WoS][Pmid][serval:BIB_240712615A76]
Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.
Cheng T., Roth B., Choi W., Black P.C., Dinney C., McConkey D.J., 2013. PloS one, 8 (2) pp. e57284. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FEF6BEA26094]
 
Guidelines for perioperative care after radical cystectomy for bladder cancer: enhanced Recovery After Surgery (ERAS(®)) society recommendations.
Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Muller S., Baldini G., Carli F. et al., 2013. Clinical Nutrition, 32 (6) pp. 879-887. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BF7B6988128]
 
Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature.
Rink M., Babjuk M., Catto J.W., Jichlinski P., Shariat S.F., Stenzl A., Stepp H., Zaak D., Witjes J.A., 2013. European Urology, 64 (4) pp. 624-638.
[DOI][WoS][Pmid][serval:BIB_82B67193B21C]
 
Immunothérapie: une nouvelle arme contre le cancer de la prostate [Immunotherapy: a therapeutic revolution against prostate cancer?].
Pracht M., Herrera F.G, Tawadros T., Berthold D., 2013. Revue Médicale Suisse, 9 (387) pp. 1070-1075. Peer-reviewed.
[Pmid][serval:BIB_872CCC33F242]
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.
Decrausaz L., Pythoud C., Domingos-Pereira S., Derré L., Jichlinski P., Nardelli-Haefliger D., 2013. Oncoimmunology, 2 (1) pp. e22944.
[URN][DOI][WoS][Pmid][serval:BIB_5658EE1F539B]
 
Intérêt d'une Consultation spécialisée multidisciplinaire en neuro-urologie et urologie fonctionnelle [Benefit of a specialized multidisciplinary clinic in neuro-urology and functional urology].
Tawadros C., Tawadros T., Julita L., Jichlinski P., Schurch B., 2013. Revue Médicale Suisse, 9 (409) pp. 2286-2288.
[Pmid][serval:BIB_304EA992D812]
 
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data.
Burger M., Grossman H.B., Droller M., Schmidbauer J., Hermann G., Drăgoescu O., Ray E., Fradet Y., Karl A., Burgués J.P. et al., 2013. European Urology, 64 (5) pp. 846-854.
[DOI][WoS][Pmid][serval:BIB_C20C3A515064]
 
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T., Alonso F., Jichlinski P., Clarke N., Calandra T., Haefliger J.A., Roger T., 2013. Endocrine-Related Cancer, 20 (1) pp. 137-149.
[DOI][WoS][Pmid][serval:BIB_4EBA811E0FF4]
Rétablissement postopératoire optimisé, applique aux patients après cystectomie [Enhanced recovery after surgery applied to cystectomy patients].
M'Baya O., Vlamopoulos Y., Hubner M., Blanc C., Jichlinski P., Cerantola Y., 2013. Revue Médicale Suisse, 9 (409) pp. 2279-82, 2284-5. Peer-reviewed.
[URN][Pmid][serval:BIB_B9BE2ABD1A42]
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.
Nazarov A.A., Baquié M., Nowak-Sliwinska P., Zava O., van Beijnum J.R., Groessl M., Chisholm D.M., Ahmadi Z., McIndoe J.S., Griffioen A.W. et al., 2013. Scientific Reports, 3 (1485) pp. 1-7.
[URN][DOI][WoS][Pmid][serval:BIB_1AA65B0D42C8]
 
Urologie."Revisitons la prostate!" [Urology. Trends in prostatic diseases in 2012].
Jichlinski P., 2013. Revue Médicale Suisse, 9 (369) pp. 147-149.
[Pmid][serval:BIB_A1CA42C94451]
 
Vaccination route matters for mucosal tumors.
Nardelli-Haefliger D., Dudda J.C., Romero P., 2013. Science Translational Medicine, 5 (172) pp. 172fs4.
[DOI][WoS][Pmid][serval:BIB_3779A3E17B52]
2012
 
Hommage au professeur Hans-Jürg Leisinger [Homage to Professor Hans-Jürg Leisinger]
Jichlinski P., Iselin C., 2012/12/05. Revue medicale suisse, 8 (365) pp. 2315-2316. Peer-reviewed.
[Pmid][serval:BIB_D66654F7CAB5]
 
An unusual phyllodes tumour of the prostate (FP17)
Fontanella S., Fritschi U., Jichlinski P., deLeval L., Rotman S., 2012/11., 78. Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, 8.-10. November 2012 pp. 575-576 dans Der Pathologe, Springer Medizin.
[serval:BIB_817F657AF57B]
 
Occlusion of seminal vesicles increases sexual activity in a mouse model.
Birkhäuser F.D., Schumacher C., Seiler R., de Meuron L., Zehnder P., Roth B., Wetterwald A., Thalmann G.N., Cecchini M.G., Studer U.E., 2012/11. European urology, 62 (5) pp. 855-862. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FA2249F3DB2B]
 
Finasteride-related Leydig cell tumour: report of a case and literature review.
Berthold D., Lhermitte B., Uffer M., Doerfler A., 2012/05. Andrologia, 44 Suppl 1 pp. 836-837.
[DOI][Pmid][serval:BIB_7B6FF11E52D6]
 
Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer?
Roth B., Zehnder P., Birkhäuser F.D., Burkhard F.C., Thalmann G.N., Studer U.E., 2012/05. The Journal of urology, 187 (5) pp. 1577-1582. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_92B69AFAD612]
 
Angiogenesis inhibition for the improvement of photodynamic therapy: The revival of a promising idea.
Weiss A., Van den Bergh H., Griffioen A.W., Nowak-Sliwinska P., 2012. Biochimica et Biophysica Acta, 1826 (1) pp. 53-70.
[DOI][WoS][Pmid][serval:BIB_3F66C008B9E0]
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.
Nowak-Sliwinska P., Weiss A., Beijnum J.R., Wong T.J., Ballini J.P., Lovisa B., van den Bergh H., Griffioen A.W., 2012. Journal of Cellular and Molecular Medicine, 16 (7) pp. 1553-1562.
[URN][DOI][WoS][Pmid][serval:BIB_E1CBA8588F2B]
 
Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'
Golka Klaus, Abreu-Villaca Yael, Anbari Attar Rowshanak, Angeli-Greaves Miriam, Aslam Muhammad, Basaran Nursen, Belik Rouslana, Butryee Chaniphun, Dalpiaz Orietta, Dzhusupov Keneshbek et al., 2012. Frontiers in Bioscience (Elite edition), 4 (8) pp. 2809-2822. Peer-reviewed.
[Pmid][serval:BIB_4410991D859C]
Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.
Pieraerts C., Martin V., Jichlinski P., Nardelli-Haefliger D., Derre L., 2012. Oncoimmunology, 1 (5) pp. 694-698.
[URN][DOI][Pmid][serval:BIB_CFDAD27012D4]
 
International collaborative proficiency study of Human Papillomavirus type 16 serology.
Eklund C., Unger E.R., Nardelli-Haefliger D., Zhou T., Dillner J., 2012. Vaccine, 30 (2) pp. 294-299.
[DOI][WoS][Pmid][serval:BIB_B9B066FBBAD8]
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2012. Mucosal Immunology, 6 (2) pp. 393-404.
[URN][DOI][WoS][Pmid][serval:BIB_688E4F5E989B]
 
L'Evidence-based nursing, un levier au changement des pratiques infirmières [Evidence-based nursing, a driver for change in nursing practice].
Codeluppi C., Silva J., Perrenoud B., 2012. Soins 771 pp. 31-33.
[Pmid][serval:BIB_8076AA0A4B47]
Percutaneous drainage and sclerotherapy as definitive treatment of renal lymphangiomatosis.
Valerio M., Meuwly J.Y., Tawadros C., Jichlinski P., 2012. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 6 (1) pp. E3-E7.
[URN][DOI][WoS][Pmid][serval:BIB_D4E2D0F25D67]
Preoperative immunonutrition in patients at nutritional risk: results of a double-blinded randomized clinical trial.
Hübner M., Cerantola Y., Grass F., Bertrand P.C., Schäfer M., Demartines N., 2012. European Journal of Clinical Nutrition, 66 (7) pp. 850-855. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_712405F742B4]
SITC 26th annual meeting - summary.
Romano E., Nardelli-Haefliger D., Donda A., Corgnac S., Romero P., 2012. Journal of Translational Medicine, 10 (1) p. 105.
[URN][DOI][WoS][Pmid][serval:BIB_D0F5F5E8AB09]
 
Troubles sexuels masculins et obésité [Male sexual dysfunction and obesity].
Lucca I., Paduch D.A., Pralong F., Vaucher L., 2012. Revue Médicale Suisse, 8 (365) pp. 2327-2330.
[Pmid][serval:BIB_2DAD861D088C]
 
Urologie [Urology in 2011].
Jichlinski P., 2012. Revue Médicale Suisse, 8 (323) pp. 61-63.
[Pmid][serval:BIB_284AE21727A0]
What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?
Nardelli-Haefliger D., Romero P., Jichlinski P., 2012. Oncoimmunology, 1 (2) pp. 242-243.
[URN][DOI][Pmid][serval:BIB_97574E7CDD78]
2011
 
Lymphadenectomy for bladder cancer: indications and controversies.
Burkhard F.C., Roth B., Zehnder P., Studer U.E., 2011/11. The Urologic clinics of North America, 38 (4) pp. 397-405, v. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2C9416C4767A]
 
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
Zehnder P., Studer U.E., Skinner E.C., Dorin R.P., Cai J., Roth B., Miranda G., Birkhäuser F., Stein J., Burkhard F.C. et al., 2011/10. The Journal of urology, 186 (4) pp. 1261-1268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6BD1FAC0791]
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
[URN][serval:BIB_EFE579EC6162]
 
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.
Zehnder P., Roth B., Birkhäuser F., Schneider S., Schmutz R., Thalmann G.N., Studer U.E., 2011/04. European urology, 59 (4) pp. 637-644. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19773C109E21]
 
Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical.
Birkhäuser F.D., Zehnder P., Roth B., Schürch L., Ochsner K., Willener R., Thalmann G.N., Burkhard F.C., Studer U.E., 2011/04. European urology, 59 (4) pp. 518-523. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0227A5B217E4]
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
[URN][serval:BIB_D67D89778302]
 
Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial.
Roth B., Birkhäuser F.D., Zehnder P., Burkhard F.C., Thalmann G.N., Studer U.E., 2011/02. European urology, 59 (2) pp. 204-210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FACDF8A04B90]
 
A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.
Longet S., Schiller J.T., Bobst M., Jichlinski P., Nardelli-Haefliger D., 2011. Journal of Virology, 85 (24) pp. 13253-13259.
[DOI][WoS][Pmid][serval:BIB_E195A2750FAA]
 
A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.
Decrausaz L., Gonçalves A.R., Domingos-Pereira S., Pythoud C., Stehle J.C., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 128 (9) pp. 2105-2113.
[DOI][WoS][Pmid][serval:BIB_AF6C31E8EF7B]
 
Animal Tissue Response To Mid-Term Electronic Modular Artificial Sphincter Implantation
Valerio M., Jichlinski P., Dahlem R., Wieland M., Tozzi P., Hayoz D., Mundy A.R., 2011. pp. e39, A92 dans AUA 2011,, Journal of Urology. Peer-reviewed.
[serval:BIB_8B7D3E9DE36A]
 
Combined radiohormonotherapy in node positive lymph node prostate cancer
Herrmann E., Boujelbene N., Ozsahin M., Khanfir K., Mirimanoff R.O., Jichlinski P., Gygi C., Zouhair A., 2011. p. 537 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
[WoS][serval:BIB_57BCC6996D76]
 
Contrôle de qualité en urologie [Quality assessment in urology].
Cerantola Y., Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2382-2387.
[Pmid][serval:BIB_9FAE2B63FC9F]
 
Ex vivo ultrasound control of resection margins during partial nephrectomy.
Doerfler A., Cerantola Y., Meuwly J.Y., Lhermitte B., Bensadoun H., Jichlinski P., 2011. Journal of Urology, 186 (6) pp. 2188-2193.
[DOI][WoS][Pmid][serval:BIB_0640D43C5622]
 
Ex-Vivo Ultransonographic Control Of Resection Margin During Partial Nephrectomy
Cerantola Y., Chollet Y., Meuwly J.Y., Jichlinski P., Doerfler A., 2011. pp. 55-56 dans 26th Annual Congress of the European Association of Urology, European Urology Supplements. Peer-reviewed.
[WoS][serval:BIB_B1B3324BED8A]
 
Ex-vivo ultrasound control of resection margins during partial nephrectomy
Cerantola Y., Doerfler A., Chollet Y., Meuwly J.Y., Jichlinsky P., 2011. pp. S21 dans European School of Oncology Educational Cancer Lugano Convention (ECCLU), Workshop on Whats New and Whats True in Genito-Urinary Oncology, Critical Reviews in Oncology Hematology. Peer-reviewed.
[WoS][serval:BIB_615C9B3CB871]
 
High magnification cystoscopy in the primary diagnosis of bladder tumors.
Jichlinski P., Lovisa B., 2011. Current Opinion in Urology, 21 (5) pp. 398-402.
[DOI][WoS][Pmid][serval:BIB_10800F85622A]
Immunonutrition in gastrointestinal surgery.
Cerantola Y., Hübner M., Grass F., Demartines N., Schäfer M., 2011. British Journal of Surgery, 98 (1) pp. 37-48. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_74B09D9DD1F9]
 
Intravaginal TLR Agonists Increase Local Vaccine-Specific CD (T-cells and Human Papillomavirus-Associated Genital-Tumor Regression in Mice
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. dans Society for Immunotherapy of Cancer SITC 26th Annual Meeting.
[serval:BIB_14A731BF59A8]
 
Intérêt de la tomographie par émission de positons couplée à la scanographie (TEP/TDM) dans les cancers urologiques [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
Boujelbene N., Prior J.O., Boubaker A., Azria D., Schaffer M., Gez E., Jichlinski P., Meuwly J.Y., Mirimanoff R.O., Ozsahin M. et al., 2011. Cancer Radiothérapie, 15 (4) pp. 307-315.
[DOI][WoS][Pmid][serval:BIB_4D5186A00AD2]
Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman.
Valerio M., Lhermitte B., Bauer J., Jichlinski P., 2011. Rare Tumors, 3 (1) pp. e9.
[URN][DOI][Pmid][serval:BIB_403FF403101F]
 
Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.
Decrausaz L., Domingos-Pereira S., Duc M., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 129 (3) pp. 762-772.
[DOI][WoS][Pmid][serval:BIB_449929460973]
 
Surveillance active du cancer de la prostate [Active surveillance in prostate cancer].
Valerio M., Vaucher L., Cerantola Y., Berthold D., Herrera F.G, Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2388-2391. Peer-reviewed.
[Pmid][serval:BIB_03B22396178D]
TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires.
Leimgruber A., Ferber M., Irving M., Hussain-Kahn H., Wieckowski S., Derré L., Rufer N., Zoete V., Michielin O., 2011. PLoS One, 6 (10) pp. e26301.
[URN][DOI][WoS][Pmid][serval:BIB_A31DB21BDF3C]
 
Testostérone et prostate [Testosterone and prostate].
Vaucher L., Paduch D.A., Jichlinski P., Pralong F., 2011. Revue Médicale Suisse, 7 (320) pp. 2399-2403.
[Pmid][serval:BIB_3D67E49A4596]
 
Urinary sphincter based on electronics and artificial muscles
Valerio M., Tozzi P., Wieland M., Hayoz D., Mundy A.R., Jichlinski P., 2011. p. 614 dans 38th Congress of the European Society for Artificial Organs (ESAO 2011) and 4th Biennial Congress of the International Federation on Artificial Organs (IFAO 2011), International Journal of Artificial Organs. Peer-reviewed.
[WoS][serval:BIB_1F148EDEC465]
 
Urinary Sphincter Based on Electronics and Artificial Muscles
Valerio M., Tozzi P., Wieland M., Hayoz D., Mundy A.R., Jichlinski P., 2011. dans 38th Congress of the European Society for Artifi cial Organs (ESAO 2011) and 4th Biennial Congress of the International Federation on Artifi cial Organs (IFAO 2011), Clinical Medicine. Life and Biomedical Sciences. Peer-reviewed.
[serval:BIB_A7371A28E44B]
 
Urologie [Urology in 2010].
Jichlinski P., 2011. Revue Médicale Suisse, 7 (277) pp. 80-82.
[Pmid][serval:BIB_C88363C16D2A]
2010
 
Limites des procédés d'investigation de la fonction érectile dans le cadre d'expertises médicolégales [Limits of the processes of investigation of the erectile function in forensic expertises].
M. Wisard , T. Krompecher , P. Mangin , P. Jichlinski , 2010/03. Revue de médecine légale, 1 (1) pp. 8-12.
[DOI][serval:BIB_BBE27CCBCE1C]
 
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.
Roth B., Wissmeyer M.P., Zehnder P., Birkhäuser F.D., Thalmann G.N., Krause T.M., Studer U.E., 2010/02. European urology, 57 (2) pp. 205-211. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4FC195DB805]
 
Apport de l'utltrasonographie dans la chirurgie d'épargne du rein et du testicule [Benefits of ultrasonography in kidney and testicular-sparing surgery].
Cerantola Y., Vaucher L., Doerfler A., Meuwly J.Y., Jichlinski P., 2010. Revue Médicale Suisse, 6 (274) pp. 2365-2368.
[Pmid][serval:BIB_EF642EE1536D]
 
Artificial Urinary Sphincter based on smart materials
Valerio M., Tozzi P., Wieland M., Conus P-A., Thevenaz P., Mundy A. R., Hayoz D., Jichlinski P., 2010. pp. S105 dans 45th Congress of the European Society for Surgical Research, British Journal of Surgery. Peer-reviewed.
[WoS][serval:BIB_83903396C275]
 
Computer aided surgery for percutaneous nephrolithotomy: Clinical requirement analysis and system design.
Oliveira-Santos T., Peterhans M., Roth B., Reyes M., Nolte L.P., Thalmann G., Weber S., 2010. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2010 pp. 442-445. Peer-reviewed.
[DOI][Pmid][serval:BIB_4B1DF9E05928]
 
Dépistage du cancer de la prostate: utilité, buts et perspectives en 2010 [Prostate cancer screening: utility, goals and perspectives in 2010].
Iselin C., Jichlinski P., 2010. Revue Médicale Suisse, 6 (274) pp. 2336-2339.
[Pmid][serval:BIB_E4A246A61C50]
 
Fluorescence of the bladder washout fluid following cystoscopy: a preliminary study
Lovisa B., Novello A.M., Jichlinski P., Van den Bergh H., Wagnieres G., 2010. pp. 75481J dans Conference on Photonic Therapeutics and Diagnostics VI, Proceedings of SPIE.
[DOI][serval:BIB_150921075F66]
 
Fluoreszenzdiagnostik bei Patienten mit nicht muskelinvasivem Harnblasenkarzinom: Ergebnisse einer Metaanalyse [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]
Kausch I., Sommerauer M., Montorsi F., Stenzl A., Jacqmin D., Jichlinski P., Jocham D., Ziegler A., Vonthein R., 2010. Aktuelle Urologie, 41 (3) pp. 171-177.
[DOI][WoS][Pmid][serval:BIB_8069F92E5260]
 
High-magnification vascular imaging to reject false-positive sites in situ during Hexvix® fluorescence cystoscopy
Lovisa Blaise, Jichlinski Patrice, Weber Bernd-Claus, Aymon Daniela, van den Bergh Hubert, Wagnières Georges , 2010. Journal of Biomedical Optics, 15 (5) p. 051606. Peer-reviewed.
[DOI][WoS][serval:BIB_C9736A0B132B]
 
Image en fluorescence en endoscopie: contribution dans la prise en charge des tumeurs de vessie [Fluorescence guided endoscopy: improvement in the management of bladder cancer].
Uffer M., Jichlinski P., 2010. Revue Médicale Suisse, 6 (274) pp. 2352-2354.
[Pmid][serval:BIB_5D2E10123C52]
 
Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
Decrausaz L., Revaz V., Bobst M., Corthésy B., Romero P., Nardelli-Haefliger D., 2010. International Journal of Cancer, 126 (10) pp. 2469-2478.
[DOI][WoS][Pmid][serval:BIB_C8FA50D44220]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University